Reference Project: The UROLIFT® System

Minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH)

Benign prostatic hyperplasia affects over 500 million men worldwide. While men can select from a variety of treatment options—from medication to major surgery—there has been a gap in the treatment continuum for a less invasive option.

Prostatic Urethral Lift using the UroLift® System was designed to meet this need. With its unique design and mechanism of action, the UroLift® System is a straightforward treatment that provides immediate, visible results.